SG Americas Securities’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,641
Closed -$79K – 3528
2021
Q3
$79K Buy
+1,641
New +$80.1K ﹤0.01% 3700
2020
Q3
– Sell
-2,108
Closed -$85K – 2939
2020
Q2
$85K Buy
+2,108
New +$78.3K ﹤0.01% 3446
2019
Q1
– Sell
-2,967
Closed -$38K – 3447
2018
Q4
$38K Buy
+2,967
New +$49.5K ﹤0.01% 2879
2016
Q2
– Sell
-933
Closed -$43K – 2746
2016
Q1
$43K Buy
+933
New +$39.4K ﹤0.01% 2792
2013
Q4
– Sell
-1,712
Closed -$180K – 2765
2013
Q3
$180K Buy
+1,712
New +$210K ﹤0.01% 2268

Other funds holding FBIO

SG Americas Securities's FBIO Position: Q4 2021 in Review

SG Americas Securities sold out of Fortress Biotech (FBIO) in Q4 2021, closing a stake of 1,641 shares — an estimated $79K sold.

SG Americas Securities first reported a position in FBIO in Q3 2013 and held it in 5 quarters. The position peaked at $180K in Q3 2013. 82 funds tracked by Wall St. Rank hold FBIO as of Q4 2021.

  • SG Americas Securities reported no remaining Fortress Biotech position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 1,641 Fortress Biotech shares in Q4 2021, an estimated $79K.
  • SG Americas Securities first reported a position in Fortress Biotech in Q3 2013 and held it in 5 quarters.
  • SG Americas Securities's Fortress Biotech position peaked at $180K in Q3 2013.
  • 82 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.